BDNF–TrkB signaling as a therapeutic target in neuropsychiatric disorders

References

• Thoenen H. Neurotrophins and activity-dependent plasticity. Prog Brain Res. 2000;128:183–191.
   PubMed Web of Science ®Google Scholar
• Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609–642.
   PubMed Web of Science ®Google Scholar
• Götz R, Raulf F, Schartl M. Brain-derived neurotrophic factor is more highly conserved in structure and function than nerve growth factor during vertebrate evolution. J Neurochem. 1992;59(2):432–442.
   Web of Science ®Google Scholar
• Ernfors P, Lee KF, Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature. 1994;368(6467):147–150.
   PubMed Web of Science ®Google Scholar
• Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1982;1(5):549–553.
   PubMed Web of Science ®Google Scholar
• Lindsay RM, Thoenen H, Barde YA. Placode and neural crest-derived sensory neurons are responsive at early developmental stages to brain-derived neurotrophic factor. Dev Biol. 1985;112(2):319–328.
   Web of Science ®Google Scholar
• Buchman VL, Davies AM. Different neurotrophins are expressed and act in a developmental sequence to promote the survival of embryonic sensory neurons. Development. 1993;118(3):989–1001.
   Web of Science ®Google Scholar
• Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol. 2010;70(5):271–288.
   PubMed Web of Science ®Google Scholar
• Wright MA, Ribera AB. Brain-derived neurotrophic factor mediates non-cell-autonomous regulation of sensory neuron position and identity. J Neurosci. 2010;30(43):14513–14521.
   Web of Science ®Google Scholar
• Lyons WE, Mamounas LA, Ricaurte GA, et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A. 1999;96(26):15239–15244.
   PubMed Web of Science ®Google Scholar
• Bosse KE, Maina FK, Birbeck JA, et al. Aberrant striatal dopamine transmitter dynamics in brain-derived neurotrophic factor-deficient mice. J Neurochem. 2012;120(3):385–395.
   PubMed Web of Science ®Google Scholar
• Bozdagi O, Rich E, Tronel S, et al. The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism. J Neurosci. 2008;28(39):9857–9869.
   Web of Science ®Google Scholar
• Inagaki T, Begum T, Reza F, et al. Brain-derived neurotrophic factor-mediated retrograde signaling required for the induction of long-term potentiation at inhibitory synapses of visual cortical pyramidal neurons. Neurosci Res. 2008;61(2):192–200.
   Web of Science ®Google Scholar
• Tanaka J, Horiike Y, Matsuzaki M, Miyazaki T, Ellis-Davies GC, Kasai H. Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science. 2008;319(5870):1683–1687.
   PubMed Web of Science ®Google Scholar
• Katoh-Semba R, Asano T, Ueda H, et al. Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J. 2002;16(10):1328–1330.
   Google Scholar
• Pencea V, Bingaman KD, Wiegand SJ, Luskin MB. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci. 2001;21(17):6706–6717.
   PubMed Web of Science ®Google Scholar
• Zigova T, Pencea V, Wiegand SJ, Luskin MB. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol Cell Neurosci. 1998;11(4):234–245.
   PubMed Web of Science ®Google Scholar
• Chan JP, Cordeira J, Calderon GA, Iyer LK, Rios M. Depletion of central BDNF in mice impedes terminal differentiation of new granule neurons in the adult hippocampus. Mol Cell Neurosci. 2008;39(3):372–383.
   Web of Science ®Google Scholar
• Lee J, Duan W, Mattson MP. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem. 2002;82(6):1367–1375.
   PubMed Web of Science ®Google Scholar
• Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res. 2007;85(3):525–535.
   PubMed Web of Science ®Google Scholar
• Chiaruttini C, Sonego M, Baj G, Simonato M, Tongiorgi E. BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae. Mol Cell Neurosci. 2008;37(1):11–19.
   PubMed Web of Science ®Google Scholar
• Tabuchi A. Synaptic plasticity-regulated gene expression: a key event in the long-lasting changes of neuronal function. Biol Pharm Bull. 2008;31(3):327–335.
   Web of Science ®Google Scholar
• Nagappan G, Lu B. Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications. Trends Neurosci. 2005;28(9):464–471.
   PubMed Web of Science ®Google Scholar
• Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001;11(3):272–280.
   PubMed Web of Science ®Google Scholar
• Woo NH, Teng HK, Siao CJ, et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci. 2005;8(8):1069–1077.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev. 2004;45(2):104–114.
   PubMedGoogle Scholar
• Duman RS. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 2004;5(1):11–25.
   PubMed Web of Science ®Google Scholar
• Ikegame T, Bundo M, Murata Y, Kasai K, Kato T, Iwamoto K. DNA methylation of the BDNF gene and its relevance to psychiatric disorders. J Hum Genet. 2013;58(7):434–438.
   PubMed Web of Science ®Google Scholar
• Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev. 2012;64(2):238–258.
   PubMed Web of Science ®Google Scholar
• Balaratnasingam S, Janca A. Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders. Pharmacol Ther. 2012;134(1):116–124.
   PubMed Web of Science ®Google Scholar
• Boulle F, van den Hove DL, Jakob SB, et al. Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry. 2012;17(6):584–596.
   PubMed Web of Science ®Google Scholar
• Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 1995;15(3 Pt 1):1768–1777.
   PubMed Web of Science ®Google Scholar
• Smith MA, Makino S, Kvetnanský R, Post RM. Effects of stress on neurotrophic factor expression in the rat brain. Ann N Y Acad Sci. 1995;771:234–239.
   PubMed Web of Science ®Google Scholar
• Nowacka M, Obuchowicz E. BDNF and VEGF in the pathogenesis of stress-induced affective diseases: an insight from experimental studies. Pharmacol Rep. 2013;65(3):535–546.
   Web of Science ®Google Scholar
• Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry. 1997;54(7):597–606.
   PubMed Web of Science ®Google Scholar
• Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436–1442.
   PubMed Web of Science ®Google Scholar
• Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–1586.
   PubMed Web of Science ®Google Scholar
• Ferrari AJ, Norman RE, Freedman G, et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. PLoS One. 2014;9(4):e91936.
   PubMed Web of Science ®Google Scholar
• Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35(2):383–402.
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Mizrahi R. Depression in Alzheimer’s disease. Expert Rev Neurother. 2006;6(6):887–895.
   Google Scholar
• Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1999;67(4):492–496.
   PubMed Web of Science ®Google Scholar
• Aarsland D, Påhlhagen S, Ballard CG, Ehrt U, Svenningsson P. Depression in Parkinson disease – epidemiology, mechanisms and management. Nat Rev Neurol. 2011;8(1):35–47.
   PubMed Web of Science ®Google Scholar
• Jacob EL, Gatto NM, Thompson A, Bordelon Y, Ritz B. Occurrence of depression and anxiety prior to Parkinson’s disease. Parkinsonism Relat Disord. 2010;16(9):576–581.
   PubMed Web of Science ®Google Scholar
• Gargiulo M, Lejeune S, Tanguy ML, et al. Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet. 2009;17(2):165–171.
   Web of Science ®Google Scholar
• Shiwach R. Psychopathology in Huntington’s disease patients. Acta Psychiatr Scand. 1994;90(4):241–246.
   Web of Science ®Google Scholar
• Shiwach RS, Norbury CG. A controlled psychiatric study of individuals at risk for Huntington’s disease. Br J Psychiatry. 1994;165(4):500–505.
   Google Scholar
• Mendenhall E, Norris SA, Shidhaye R, Prabhakaran D. Depression and type 2 diabetes in low- and middle-income countries: a systematic review. Diabetes Res Clin Pract. 2014;103(2):276–285.
   PubMed Web of Science ®Google Scholar
• Charlson FJ, Moran AE, Freedman G, et al. The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Med. 2013;11:250.
   PubMed Web of Science ®Google Scholar
• Halaris A. Comorbidity between depression and cardiovascular disease. Int Angiol. 2009;28(2):92–99.
   Web of Science ®Google Scholar
• Halaris A. Inflammation, heart disease, and depression. Curr Psychiatry Rep. 2013;15(10):400.
   PubMed Web of Science ®Google Scholar
• McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry. 2008;79(8):854–862.
   Web of Science ®Google Scholar
• Duman RS, Malberg J, Nakagawa S, D’Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry. 2000;48(8):732–739.
   PubMed Web of Science ®Google Scholar
• Duman RS. Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry. 2002;17 Suppl 3:306–310.
   Google Scholar
• Manji HK, Quiroz JA, Sporn J, et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry. 2003;53(8):707–742.
   PubMed Web of Science ®Google Scholar
• Czéh B, Simon M. [Neuroplasticity and depression]. Psychiatr Hung. 2005;20(1):4–17. Hungarian.
   Google Scholar
• Cotter DR, Pariante CM, Everall IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull. 2001;55(5):585–595.
   Web of Science ®Google Scholar
• Beasley CL, Cotter DR, Everall IP. Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration. Mol Psychiatry. 2002;7(6):564–570.
   Web of Science ®Google Scholar
• Ongür D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95(22):13290–13295.
   PubMed Web of Science ®Google Scholar
• Rajkowska G. Cell pathology in mood disorders. Semin Clin Neuropsychiatry. 2002;7(4):281–292.
   Google Scholar
• Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci. 1996;19:289–317.
   PubMed Web of Science ®Google Scholar
• McAllister AK. Neurotrophins and neuronal differentiation in the central nervous system. Cell Mol Life Sci. 2001;58(8):1054–1060.
   PubMed Web of Science ®Google Scholar
• McAllister AK, Katz LC, Lo DC. Neurotrophins and synaptic plasticity. Annu Rev Neurosci. 1999;22:295–318.
   PubMed Web of Science ®Google Scholar
• Altar CA. Neurotrophins and depression. Trends Pharmacol Sci. 1999;20(2):59–61.
   PubMed Web of Science ®Google Scholar
• Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112(2):257–269.
   PubMed Web of Science ®Google Scholar
• Chiaruttini C, Vicario A, Li Z, et al. Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation. Proc Natl Acad Sci U S A. 2009;106(38):16481–16486.
   PubMed Web of Science ®Google Scholar
• Kim SN, Kang DH, Yun JY, et al. Impact of the BDNF Val66Met polymorphism on regional brain gray matter volumes: relevance to the stress response. Psychiatry Investig. 2013;10(2):173–179.
   Web of Science ®Google Scholar
• Hosang GM, Shiles C, Tansey KE, McGuffin P, Uher R. Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med. 2014;12:7.
   PubMed Web of Science ®Google Scholar
• Lee Y, Lim SW, Kim SY, et al. Association between the BDNF Val66Met polymorphism and chronicity of depression. Psychiatry Investig. 2013;10(1):56–61.
   PubMed Web of Science ®Google Scholar
• Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;37(12):1553–1561.
   PubMed Web of Science ®Google Scholar
• Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002;328(3):261–264.
   PubMed Web of Science ®Google Scholar
• Yoshimura R, Umene-Nakano W, Hoshuyama T, et al. Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls. Hum Psychopharmacol. 2010;25(7–8):566–569.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Ishikawa M, Niitsu T, et al. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One. 2012;7(8):e42676.
   PubMed Web of Science ®Google Scholar
• Bocchio-Chiavetto L, Bagnardi V, Zanardini R, et al. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry. 2010;11(6):763–773.
   PubMed Web of Science ®Google Scholar
• Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. 2003; 54(1):70–75.
   PubMed Web of Science ®Google Scholar
• Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002;109(2):143–148.
   PubMed Web of Science ®Google Scholar
• Molendijk ML, Bus BA, Spinhoven P, et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry. 2011;16(11):1088–1095.
   PubMed Web of Science ®Google Scholar
• Munno D, Sterpone S, Fania S, et al. Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine. Panminerva Med. 2013;55(4):377–384.
   Web of Science ®Google Scholar
• Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Mol Psychiatry. 2014;19(7):791–800.
   PubMed Web of Science ®Google Scholar
• Bus BA, Molendijk ML, Penninx BW, et al. Low serum BDNF levels in depressed patients cannot be attributed to individual depressive symptoms or symptom cluster. World J Biol Psychiatry. Epub November 13, 2013.
   Google Scholar
• Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry. 2003;60(8):804–815.
   PubMed Web of Science ®Google Scholar
• Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res. 2005;136(1–2):29–37.
   PubMedGoogle Scholar
• Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001;50(4):260–265.
   PubMed Web of Science ®Google Scholar
• Coffey CE, Wilkinson WE, Weiner RD, et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry. 1993;50(1):7–16.
   Web of Science ®Google Scholar
• Frodl T, Reinhold E, Koutsouleris N, Reiser M, Meisenzahl EM. Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression. J Psychiatr Res. 2010;44(13):799–807.
   PubMed Web of Science ®Google Scholar
• Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A. 1996;93(9):3908–3913.
   PubMed Web of Science ®Google Scholar
• Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci. 1999;19(12):5034–5043.
   PubMed Web of Science ®Google Scholar
• Axelson DA, Doraiswamy PM, McDonald WM, et al. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res. 1993;47(2):163–173.
   Web of Science ®Google Scholar
• Frodl T, Schüle C, Schmitt G, et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry. 2007;64(4):410–416.
   PubMed Web of Science ®Google Scholar
• Huang Y, Coupland NJ, Lebel RM, et al. Structural changes in hippocampal subfields in major depressive disorder: a high-field magnetic resonance imaging study. Biol Psychiatry. 2013;74(1):62–68.
   Web of Science ®Google Scholar
• Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippo- campal volume loss. Am J Psychiatry. 2003;160(8):1516–1518.
   PubMed Web of Science ®Google Scholar
• Smith R, Chen K, Baxter L, Fort C, Lane RD. Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex. J Affect Disord. 2013;146(3):414–419.
   PubMed Web of Science ®Google Scholar
• Lacerda AL, Keshavan MS, Hardan AY, et al. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry. 2004;55(4):353–358.
   PubMed Web of Science ®Google Scholar
• Lavretsky H, Roybal DJ, Ballmaier M, Toga AW, Kumar A. Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression. J Clin Psychiatry. 2005;66(8):964–967.
   Web of Science ®Google Scholar
• Eker C, Kitis O, Taneli F, et al. Correlation of serum BDNF levels with hippocampal volumes in first episode, medication-free depressed patients. Eur Arch Psychiatry Clin Neurosci. 2010;260(7):527–533.
   Web of Science ®Google Scholar
• Lorenzetti V, Allen NB, Fornito A, Yücel M. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord. 2009;117(1–2):1–17.
   PubMed Web of Science ®Google Scholar
• Chen ZY, Jing D, Bath KG, et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science. 2006;314(5796):140–143.
   PubMed Web of Science ®Google Scholar
• Cirulli F, Francia N, Berry A, Aloe L, Alleva E, Suomi SJ. Early life stress as a risk factor for mental health: role of neurotrophins from rodents to non-human primates. Neurosci Biobehav Rev. 2009;33(4):573–585.
   PubMed Web of Science ®Google Scholar
• Cirulli F, Berry A, Bonsignore LT, et al. Early life influences on emotional reactivity: evidence that social enrichment has greater effects than handling on anxiety-like behaviors, neuroendocrine responses to stress and central BDNF levels. Neurosci Biobehav Rev. 2010;34(6):808–820.
   Web of Science ®Google Scholar
• Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav. 1997;56(1):131–137.
   Web of Science ®Google Scholar
• Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci. 2002;22(8):3251–3261.
   PubMed Web of Science ®Google Scholar
• Branchi I, D’Andrea I, Sietzema J, et al. Early social enrichment augments adult hippocampal BDNF levels and survival of BrdU-positive cells while increasing anxiety- and “depression”-like behavior. J Neurosci Res. 2006;83(6):965–973.
   Web of Science ®Google Scholar
• Montkowski A, Holsboer F. Intact spatial learning and memory in transgenic mice with reduced BDNF. Neuroreport. 1997;8(3):779–782.
   Web of Science ®Google Scholar
• MacQueen GM, Ramakrishnan K, Croll SD, et al. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci. 2001;115(5):1145–1153.
   PubMed Web of Science ®Google Scholar
• Gorski JA, Balogh SA, Wehner JM, Jones KR. Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience. 2003;121(2):341–354.
   PubMed Web of Science ®Google Scholar
• Saarelainen T, Hendolin P, Lucas G, et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci. 2003;23(1):349–357.
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: A review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2014;53:23–34.
   PubMed Web of Science ®Google Scholar
• Ratnayake U, Quinn T, Walker DW, Dickinson H. Cytokines and the neurodevelopmental basis of mental illness. Front Neurosci. 2013;7:180.
   Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012;139(3):230–239.
   PubMed Web of Science ®Google Scholar
• Anisman H, Hayley S, Turrin N, Merali Z. Cytokines as a stressor: implications for depressive illness. Int J Neuropsychopharmacol. 2002;5(4):357–373.
   PubMed Web of Science ®Google Scholar
• Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev. 1998;105(1):83–107.
   PubMed Web of Science ®Google Scholar
• Churchill L, Taishi P, Wang M, et al. Brain distribution of cytokine mRNA induced by systemic administration of interleukin-1beta or tumor necrosis factor alpha. Brain Res. 2006;1120(1):64–73.
   Google Scholar
• Kenis G, Prickaerts J, van Os J, et al. Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor? Int J Neuropsychopharmacol. 2011;14(2):247–253.
   Web of Science ®Google Scholar
• Lotrich FE, Albusaysi S, Ferrell RE. Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-alpha treatment. Neuropsychopharmacology. 2013;38(6):985–995.
   Web of Science ®Google Scholar
• Guan Z, Fang J. Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun. 2006;20(1):64–71.
   Web of Science ®Google Scholar
• Tong L, Balazs R, Soiampornkul R, Thangnipon W, Cotman CW. Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol Aging. 2008;29(9):1380–1393.
   PubMed Web of Science ®Google Scholar
• Rage F, Silhol M, Tapia-Arancibia L. IL-1beta regulation of BDNF expression in rat cultured hypothalamic neurons depends on the presence of glial cells. Neurochem Int. 2006;49(5):433–441.
   Web of Science ®Google Scholar
• Cortese GP, Barrientos RM, Maier SF, Patterson SL. Aging and a peripheral immune challenge interact to reduce mature brain-derived neurotrophic factor and activation of TrkB, PLCgamma1, and ERK in hippocampal synaptoneurosomes. J Neurosci. 2011;31(11):4274–4279.
   PubMed Web of Science ®Google Scholar
• Peng CH, Chiou SH, Chen SJ, et al. Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neuropsychopharmacol. 2008;18(2):128–140.
   Web of Science ®Google Scholar
• Angelucci F, Brenè S, Mathé AA. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry. 2005;10(4):345–352.
   PubMed Web of Science ®Google Scholar
• Thompson Ray M, Weickert CS, Wyatt E, Webster MJ. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci. 2011;36(3):195–203.
   PubMed Web of Science ®Google Scholar
• Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry. 2003;8(6):592–610.
   PubMed Web of Science ®Google Scholar
• Weickert CS, Ligons DL, Romanczyk T, et al. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry. 2005;10(7):637–650.
   PubMed Web of Science ®Google Scholar
• Durany N, Michel T, Zöchling R, et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res. 2001;52(1–2):79–86.
   PubMed Web of Science ®Google Scholar
• Iritani S, Niizato K, Nawa H, Ikeda K, Emson PC. Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(5):801–807.
   Web of Science ®Google Scholar
• Takahashi M, Shirakawa O, Toyooka K, et al. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry. 2000;5(3):293–300.
   PubMed Web of Science ®Google Scholar
• Grillo RW, Ottoni GL, Leke R, Souza DO, Portela LV, Lara DR. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J Psychiatr Res. 2007;41(1–2):31–35.
   Web of Science ®Google Scholar
• Ikeda Y, Yahata N, Ito I, Nagano M, et al. Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophr Res. 2008;101(1–3):58–66.
   Web of Science ®Google Scholar
• Tan YL, Zhou DF, Cao LY, Zou YZ, Zhang XY. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci Lett. 2005;382(1–2):27–32.
   Web of Science ®Google Scholar
• Toyooka K, Asama K, Watanabe Y, et al. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res. 2002;110(3):249–257.
   PubMed Web of Science ®Google Scholar
• Xiu MH, Hui L, Dang YF, et al. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1508–1512.
   Web of Science ®Google Scholar
• Chen da C1, Wang J, Wang B, et al. Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl). 2009;207(3):375–380.
   Web of Science ®Google Scholar
• Palomino A, Vallejo-Illarramendi A, González-Pinto A, et al. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr Res. 2006;86(1–3):321–322.
   Web of Science ®Google Scholar
• Rizos EN, Rontos I, Laskos E, et al. Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1308–1311.
   PubMed Web of Science ®Google Scholar
• Reis HJ, Nicolato R, Barbosa IG, Teixeira do Prado PH, Romano-Silva MA, Teixeira AL. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett. 2008;439(2):157–159.
   PubMed Web of Science ®Google Scholar
• Huang TL, Lee CT. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. J Psychiatr Res. 2006;40(7):664–668.
   PubMed Web of Science ®Google Scholar
• Shimizu E, Hashimoto K, Watanabe H, et al. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett. 2003;351(2):111–114.
   Web of Science ®Google Scholar
• Komulainen P, Pedersen M, Hänninen T, et al. BDNF is a novel marker of cognitive function in ageing women: the DR’s EXTRA Study. Neurobiol Learn Mem. 2008;90(4):596–603.
   PubMed Web of Science ®Google Scholar
• Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry. 2011;16(9):960–972.
   PubMed Web of Science ®Google Scholar
• Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature. 2001;411(6833):86–89.
   PubMed Web of Science ®Google Scholar
• Hasbi A, Fan T, Alijaniaram M, et al. Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci U S A. 2009;106(50):21377–21382.
   Web of Science ®Google Scholar
• Nandra KS, Agius M. The differences between typical and atypical antipsychotics: the effects on neurogenesis. Psychiatr Danub. 2012; 24 Suppl 1:S95–S99.
   Google Scholar
• Yoshimura R, Hori H, Ikenouchi-Sugita A, et al. Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients. Hum Psychopharmacol. 2012;27(1):33–38.
   Web of Science ®Google Scholar
• Pedrini M, Chendo I, Grande I, et al. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation. Neurosci Lett. 2011;491(3):207–210.
   Web of Science ®Google Scholar
• Huang TL. Effects of antipsychotics on the BDNF in schizophrenia. Curr Med Chem. 2013;20(3):345–350.
   Web of Science ®Google Scholar
• Lee JG, Cho HY, Park SW, Seo MK, Kim YH. Effects of olanzapine on brain-derived neurotrophic factor gene promoter activity in SH-SY5Y neuroblastoma cells. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(6):1001–1006.
   PubMed Web of Science ®Google Scholar
• Fumagalli F, Calabrese F, Luoni A, Bolis F, Racagni G, Riva MA. Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress. Int J Neuropsychopharmacol. 2012;15(2):235–346.
   PubMed Web of Science ®Google Scholar
• Chao HM, Kao HT, Porton B. BDNF Val66Met variant and age of onset in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(4):505–506.
   Web of Science ®Google Scholar
• Hong CJ, Yu YW, Lin CH, Tsai SJ. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett. 2003;349(3):206–208.
   PubMed Web of Science ®Google Scholar
• Nikolac Perkovic M, Nedic Erjavec G, Zivkovic M, et al. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients. Psychopharmacology (Berl). Epub March 5, 2014.
   Google Scholar
• Zhang JP, Lencz T, Geisler S, DeRosse P, Bromet EJ, Malhotra AK. Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia. Schizophr Res. 2013;146(1–3):285–288.
   PubMed Web of Science ®Google Scholar
• Buckley PF, Pillai A, Howell KR. Brain-derived neurotrophic factor:findings in schizophrenia. Curr Opin Psychiatry. 2011;24(2):122–127.
   Web of Science ®Google Scholar
• Rybakowski JK. BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics. 2008;9(11):1589–1593.
   Web of Science ®Google Scholar
• Ho BC, Milev P, O’Leary DS, Librant A, Andreasen NC, Wassink TH. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry. 2006;63(7):731–740.
   PubMed Web of Science ®Google Scholar
• Mandelman SD, Grigorenko EL. BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association. Genes Brain Behav. 2012;11(2):127–136.
   PubMed Web of Science ®Google Scholar
• Aas M, Haukvik UK, Djurovic S, et al. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses. Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:181–188.
   Web of Science ®Google Scholar
• Klug M, Hill RA, Choy KH, Kyrios M, Hannan AJ, van den Buuse M. Long-term behavioral and NMDA receptor effects of young-adult corticosterone treatment in BDNF heterozygous mice. Neurobiol Dis. 2012;46(3):722–731.
   Web of Science ®Google Scholar
• Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry. 2007;12(7):656–670.
   PubMed Web of Science ®Google Scholar
• Monteggia LM, Luikart B, Barrot M, et al. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry. 2007;61(2):187–197.
   PubMed Web of Science ®Google Scholar
• Guo C, Yang Y, Su Y, Si T. Postnatal BDNF expression profiles in prefrontal cortex and hippocampus of a rat schizophrenia model induced by MK-801 administration. J Biomed Biotechnol. 2010;2010:783297.
   PubMedGoogle Scholar
• Liu F, Zou X, Sadovova N, et al. Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia. Int J Dev Neurosci. 2011;29(3):351–358.
   Web of Science ®Google Scholar
• Kaminitz A, Barzilay R, Segal H, et al. Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression. World J Biol Psychiatry. 2014;15(1):76–82.
   Web of Science ®Google Scholar
• Hill RA, Wu YW, Gogos A, van den Buuse M. Sex-dependent alterations in BDNF-TrkB signaling in the hippocampus of reelin heterozygous mice: a role for sex steroid hormones. J Neurochem. 2013;126(3):389–399.
   Web of Science ®Google Scholar
• Gibney SM, McGuinness B, Prendergast C, Harkin A, Connor TJ. I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain Behav Immun. 2013;28:170–181.
   PubMed Web of Science ®Google Scholar
• Nawa H, Takahashi M, Patterson PH. Cytokine and growth factor involvement in schizophrenia – support for the developmental model. Mol Psychiatry. 2000;5(6):594–603.
   PubMed Web of Science ®Google Scholar
• Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70(7):663–671.
   PubMed Web of Science ®Google Scholar
• Mondelli V, Cattaneo A, Belvederi Murri M, et al. Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. J Clin Psychiatry. 2011;72(12):1677–1684.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.
   PubMed Web of Science ®Google Scholar
• Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet. 2003;123C(1):48–58.
   Web of Science ®Google Scholar
• Maier W, Lichtermann D, Minges J, et al. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch Gen Psychiatry. 1993;50(11):871–883.
   Web of Science ®Google Scholar
• Fan J, Sklar P. Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism. Novartis Found Symp. 2008;289:60–72; discussion 72–73, 87–93.
   PubMedGoogle Scholar
• Rabie MA, Mohsen M, Ibrahim M, El-Sawy Mahmoud R. Serum level of brain derived neurotrophic factor (BDNF) among patients with bipolar disorder. J Affect Disord. 2014;162:67–72.
   Web of Science ®Google Scholar
• Fernandes BS, Gama CS, Ceresér KM, et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res. 2011;45(8):995–1004.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang C, Fan J, et al. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study. Br J Psychiatry. 2014;205(1):29–35.
   PubMed Web of Science ®Google Scholar
• Kenna HA, Reynolds-May M, Stepanenko A, Ketter TA, Hallmayer J, Rasgon NL. Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women. J Affect Disord. 2014;156:214–218.
   Web of Science ®Google Scholar
• Barbosa IG, Rocha NP, Miranda AS, et al. Increased BDNF levels in long-term bipolar disorder patients. Rev Bras Psiquiatr. 2013;35(1):67–69.
   PubMed Web of Science ®Google Scholar
• Grande I, Kapczinski F, Stertz L, et al. Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: an open-label trial in drug-free patients with bipolar disorder. J Psychiatr Res. 2012;46(11):1511–1514.
   PubMed Web of Science ®Google Scholar
• Ray MT, Shannon Weickert C, Webster MJ. Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders. Transl Psychiatry. 2014;4:e389.
   PubMed Web of Science ®Google Scholar
• Dunham JS, Deakin JF, Miyajima F, Payton A, Toro CT. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J Psychiatr Res. 2009;43(14):1175–1184.
   PubMed Web of Science ®Google Scholar
• Teh CA, Lee TS, Kuchibhatla M, et al. Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology. PLoS One. 2012;7(7):e38469.
   PubMed Web of Science ®Google Scholar
• Brietzke E, Stertz L, Fernandes BS, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009;116(3):214–217.
   PubMed Web of Science ®Google Scholar
• Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12(4):447–458.
   PubMed Web of Science ®Google Scholar
• Goldstein BI, Collinger KA, Lotrich F, et al. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. J Child Adolesc Psychopharmacol. 2011;21(5):479–484.
   PubMed Web of Science ®Google Scholar
• Homberg JR, Molteni R, Calabrese F, Riva MA. The serotonin-BDNF duo: Developmental implications for the vulnerability to psychopathology. Neurosci Biobehav Rev. 2014;43C:35–47.
   Web of Science ®Google Scholar
• Hill RA, Murray SS, Halley PG, Binder MD, Martin SJ, van den Buuse M. Brain-derived neurotrophic factor expression is increased in the hippocampus of 5-HT(2C) receptor knockout mice. Hippocampus. 2011;21(4):434–445.
   Web of Science ®Google Scholar
• Wu YC, Hill RA, Klug M, van den Buuse M. Sex-specific and region-specific changes in BDNF-TrkB signalling in the hippocampus of 5-HT1A receptor and BDNF single and double mutant mice. Brain Res. 2012;1452:10–17.
   PubMed Web of Science ®Google Scholar
• Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59(12):1116–1127.
   PubMed Web of Science ®Google Scholar
• Allaman I, Fiumelli H, Magistretti PJ, Martin JL. Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology (Berl). 2011;216(1):75–84.
   PubMed Web of Science ®Google Scholar
• Gervasoni N, Aubry JM, Bondolfi G, et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology. 2005;51(4):234–238.
   PubMed Web of Science ®Google Scholar
• Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 1996;16(7):2365–2372.
   PubMed Web of Science ®Google Scholar
• Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995;15(11):7539–7547.
   PubMed Web of Science ®Google Scholar
• Monteggia LM, Barrot M, Powell CM, et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci U S A. 2004;101(29):10827–10832.
   Web of Science ®Google Scholar
• Koponen E, Rantamäki T, Voikar V, Saarelainen T, MacDonald E, Castrén E. Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines. Cell Mol Neurobiol. 2005;25(6):973–980.
   Web of Science ®Google Scholar
• Liu X, Chan CB, Qi Q, et al. Optimization of a small tropomyosin-related kinase B (TrkB) agonist 7,8-dihydroxyflavone active in mouse models of depression. J Med Chem. 2012;55(19):8524–8537.
   PubMed Web of Science ®Google Scholar
• Kozisek ME, Middlemas D, Bylund DB. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther. 2008;117(1):30–51.
   PubMed Web of Science ®Google Scholar
• Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008;33(1):88–109.
   PubMed Web of Science ®Google Scholar
• Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007;10(9):1089–1093.
   PubMed Web of Science ®Google Scholar
• Groves JO. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry. 2007;12(12):1079–1088.
   PubMed Web of Science ®Google Scholar
• Sairanen M, Lucas G, Ernfors P, Castrén M, Castrén E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci. 2005;25(5):1089–1094.
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34(1):13–25.
   PubMed Web of Science ®Google Scholar
• Katsuki A, Yoshimura R, Kishi T, et al. Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD). CNS Spectr. 2012;17(3):155–163.
   PubMed Web of Science ®Google Scholar
• Schmidt HD, Duman RS. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology. 2010;35(12):2378–2391.
   PubMed Web of Science ®Google Scholar
• Pearse RN, Swendeman SL, Li Y, Rafii D, Hempstead BL. A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival. Blood. 2005;105(11):4429–4436.
   PubMed Web of Science ®Google Scholar
• Adessi C, Soto C. Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem. 2002;9(9):963–978.
   PubMed Web of Science ®Google Scholar
• Egleton RD, Davis TP. Development of neuropeptide drugs that cross the blood-brain barrier. NeuroRx. 2005;2(1):44–53.
   PubMedGoogle Scholar
• Brown RE. The life and work of Donald Olding Hebb. Acta Neurol Taiwan. 2006;15(2):127–142.
   Google Scholar
• van Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment. Nat Rev Neurosci. 2000;1(3):191–198.
   PubMed Web of Science ®Google Scholar
• Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci. 2006;7(9):697–709.
   PubMed Web of Science ®Google Scholar
• Rosenzweig MR, Krech D, Bennett EL, Diamond MC. Effects of environmental complexity and training on brain chemistry and anatomy: a replication and extension. J Comp Physiol Psychol. 1962;55:429–437.
   PubMed Web of Science ®Google Scholar
• Altman J, Das GD, Autoradiographic examination of the effects of enriched environment on the rate of glial multiplication in the adult rat brain. Nature. 1964;204:1161–1163.
   PubMed Web of Science ®Google Scholar
• Diamond MC, Krech D, Rosenzweig MR. The effects of an enriched environment on the histology of the rat cerebral cortex. J Comp Neurol. 1964;123:111–120.
   PubMed Web of Science ®Google Scholar
• Ma XC, Jiang D, Jiang WH, et al. Social isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stress. PLoS One. 2011;6(6):e20955.
   PubMed Web of Science ®Google Scholar
• Martin AL, Brown RE. The lonely mouse: verification of a separation-induced model of depression in female mice. Behav Brain Res. 2010;207(1):196–207.
   Web of Science ®Google Scholar
• Brenes Sáenz JC, Villagra OR, Fornaguera Trías J. Factor analysis of Forced Swimming test, Sucrose Preference test and Open Field test on enriched, social and isolated reared rats. Behav Brain Res. 2006;169(1):57–65.
   Web of Science ®Google Scholar
• Koh S, Magid R, Chung H, Stine CD, Wilson DN. Depressive behavior and selective down-regulation of serotonin receptor expression after early-life seizures: reversal by environmental enrichment. Epilepsy Behav. 2007;10(1):26–31.
   Web of Science ®Google Scholar
• Richter SH, Zeuch B, Riva MA, Gass P, Vollmayr B. Environmental enrichment ameliorates depressive-like symptoms in young rats bred for learned helplessness. Behav Brain Res. 2013;252:287–292.
   Web of Science ®Google Scholar
• Hendriksen H, Meulendijks D, Douma TN, et al. Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats. Neuropharmacology. 2012;62(1):270–277.
   Web of Science ®Google Scholar
• Pang TY, Du X, Catchlove WA, Renoir T, Lawrence AJ, Hannan AJ. Positive environmental modification of depressive phenotype and abnormal hypothalamic-pituitary-adrenal axis activity in female C57BL/6J mice during abstinence from chronic ethanol consumption. Front Pharmacol. 2013;4:93.
   Web of Science ®Google Scholar
• Pang TY, Du X, Zajac MS, Howard ML, Hannan AJ. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington’s disease. Hum Mol Genet. 2009;18(4):753–766.
   Web of Science ®Google Scholar
• Tanti A, Westphal WP, Girault V, et al. Region-dependent and stage-specific effects of stress, environmental enrichment, and antidepressant treatment on hippocampal neurogenesis. Hippocampus. 2013;23(9):797–811.
   PubMed Web of Science ®Google Scholar
• Schloesser RJ, Lehmann M, Martinowich K, Manji HK, Herkenham M. Environmental enrichment requires adult neurogenesis to facilitate the recovery from psychosocial stress. Mol Psychiatry. 2010;15(12):1152–1163.
   PubMed Web of Science ®Google Scholar
• Rossi C, Angelucci A, Costantin L, et al. Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur J Neurosci. 2006;24(7):1850–1856.
   PubMed Web of Science ®Google Scholar
• Ravenelle R, Santolucito HB, Byrnes EM, Byrnes JJ, Donaldson ST. Housing environment modulates physiological and behavioral responses to anxiogenic stimuli in trait anxiety male rats. Neuroscience. 2014;270:76–87.
   PubMed Web of Science ®Google Scholar
• Chourbaji S, Brandwein C, Vogt MA, Dormann C, Hellweg R, Gass P. Nature vs nurture: can enrichment rescue the behavioural phenotype of BDNF heterozygous mice? Behav Brain Res. 2008;192(2):254–258.
   Web of Science ®Google Scholar
• Chourbaji S, Hörtnagl H, Molteni R, Riva MA, Gass P, Hellweg R. The impact of environmental enrichment on sex-specific neurochemical circuitries – effects on brain-derived neurotrophic factor and the serotonergic system. Neuroscience. 2012;220:267–276.
   Web of Science ®Google Scholar
• Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br J Anaesth. 2001;87(1):3–11.
   PubMed Web of Science ®Google Scholar
• Singhal G, Jaehne EJ, Corrigan F, Baune BT. Cellular and molecular mechanisms of immunomodulation in the brain through environmental enrichment. Front Cell Neuroscil. 2014;8:97.
   Google Scholar
• Cruwys T, Dingle GA, Haslam C, Haslam SA, Jetten J, Morton TA. Social group memberships protect against future depression, alleviate depression symptoms and prevent depression relapse. Soc Sci Med. 2013;98:179–186.
   PubMed Web of Science ®Google Scholar
• Terzian E, Tognoni G, Bracco R, et al; SIRS (Studio di Intervento sulla Rete Sociale [Social Network Intervention Study]) Collaborative Study Group. Social network intervention in patients with schizophrenia and marked social withdrawal: a randomized controlled study. Can J Psychiatry. 2013;58(11):622–631.
   Web of Science ®Google Scholar
• Kinser PA, Bourguignon C, Taylor AG, Steeves R. “A feeling of connectedness”: perspectives on a gentle yoga intervention for women with major depression. Issues Ment Health Nurs. 2013;34(6):402–411.
   PubMed Web of Science ®Google Scholar
• Pinniger R, Brown RF, Thorsteinsson EB, McKinley P. Argentine tango dance compared with mindfulness meditation and a waiting-list control: a randomised trial for treating depression. Complement Ther Med. 2012;20(6):377–384.
   PubMed Web of Science ®Google Scholar
• Field T, Diego M, Hernandez-Reif M, Medina L, Delgado J, Hernandez A. Yoga and massage therapy reduce prenatal depression and prematurity. J Bodyw Mov Ther. 2012;16(2):204–209.
   Google Scholar
• Hou WH, Chiang PT, Hsu TY, Chiu SY, Yen YC. Treatment effects of massage therapy in depressed people: a meta-analysis. J Clin Psychiatry. 2010;71(7):894–901.
   PubMed Web of Science ®Google Scholar
• Cramer H, Lauche R, Klose P, Langhorst J, Dobos G. Yoga for schizophrenia: a systematic review and meta-analysis. BMC Psychiatry. 2013;13:32.
   Web of Science ®Google Scholar
• Erkkilä J, Punkanen M, Fachner J. Individual music therapy for depression: randomised controlled trial. Br J Psychiatry. 2011;199(2):132–139.
   PubMed Web of Science ®Google Scholar
• Fachner J, Gold C, Erkkilä J. Music therapy modulates fronto-temporal activity in rest-EEG in depressed clients. Brain Topogr. 2013;26(2):338–354.
   PubMed Web of Science ®Google Scholar
• Chan MF, Wong ZY, Thayala NV. The effectiveness of music listening in reducing depressive symptoms in adults: a systematic review. Complement Ther Med. 2011;19(6):332–348.
   PubMed Web of Science ®Google Scholar
• Mössler K, Chen X, Heldal TO, Gold C. Music therapy for people with schizophrenia and schizophrenia-like disorders. Cochrane Database Syst Rev. 2011;(12):CD004025.
   Google Scholar
• Li WJ, Yu H, Yang JM, et al. Anxiolytic effect of music exposure on BDNFMet/Met transgenic mice. Brain Res. 2010;1347:71–79.
   PubMed Web of Science ®Google Scholar
• Angelucci F, Ricci E, Padua L, Sabino A, Tonali PA. Music exposure differentially alters the levels of brain-derived neurotrophic factor and nerve growth factor in the mouse hypothalamus. Neurosci Lett. 2007;429(2–3):152–155.
   Web of Science ®Google Scholar
• Angelucci F, Fiore M, Ricci E, Padua L, Sabino A, Tonali PA. Investigating the neurobiology of music: brain-derived neurotrophic factor modulation in the hippocampus of young adult mice. Behav Pharmacol. 2007;18(5–6):491–496.
   Web of Science ®Google Scholar
• Boso M, Politi P, Barale F, Enzo E. Neurophysiology and neurobiology of the musical experience. Funct Neurol. 2006;21(4):187–191.
   PubMed Web of Science ®Google Scholar
• Driessen E, Hollon SD. Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators. Psychiatr Clin North Am. 2010;33(3):537–555.
   PubMed Web of Science ®Google Scholar
• Rathod S, Phiri P, Kingdon D. Cognitive behavioral therapy for schizophrenia. Psychiatr Clin North Am. 2010;33(3):527–536.
   PubMed Web of Science ®Google Scholar
• Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials. Psychol Med. 2010;40(1):9–24.
   Web of Science ®Google Scholar
• Kobilo T, Liu QR, Gandhi K, Mughal M, Shaham Y, van Praag H. Running is the neurogenic and neurotrophic stimulus in environmental enrichment. Learn Mem. 2011;18(9):605–609.
   PubMed Web of Science ®Google Scholar
• Grégoire CA, Bonenfant D, Le Nguyen A, Aumont A, Fernandes KJ. Untangling the influences of voluntary running, environmental complexity, social housing and stress on adult hippocampal neurogenesis. PLoS One. 2014;9(1):e86237.
   Web of Science ®Google Scholar
• Kerse N, Hayman KJ, Moyes SA, et al. Home-based activity program for older people with depressive symptoms: DeLLITE – a randomized controlled trial. Ann Fam Med. 2010;8(3):214–223.
   Web of Science ®Google Scholar
• Lampinen P, Heikkinen E. Reduced mobility and physical activity as predictors of depressive symptoms among community-dwelling older adults: an eight-year follow-up study. Aging Clin Exp Res. 2003;15(3):205–211.
   PubMed Web of Science ®Google Scholar
• Vankova H, Holmerova I, Machacova K, Volicer L, Veleta P, Celko AM. The effect of dance on depressive symptoms in nursing home residents. J Am Med Dir Assoc. Epub June 6, 2014.
   Google Scholar
• Suija K, Timonen M, Suviola M, Jokelainen J, Järvelin MR, Tammelin T. The association between physical fitness and depressive symptoms among young adults: results of the Northern Finland 1966 birth cohort study. BMC Public Health. 2013;13:535.
   Web of Science ®Google Scholar
• McKercher C, Patton GC, Schmidt MD, Venn AJ, Dwyer T, Sanderson K. Physical activity and depression symptom profiles in young men and women with major depression. Psychosom Med. 2013;75(4):366–374.
   PubMed Web of Science ®Google Scholar
• Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69(7):587–596.
   PubMed Web of Science ®Google Scholar
• Russo-Neustadt AA, Alejandre H, Garcia C, Ivy AS, Chen MJ. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology. 2004;29(12):2189–2199.
   PubMed Web of Science ®Google Scholar
• Scheewe TW, Backx FJ, Takken T, et al. Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatr Scand. 2013;127(6):464–473.
   PubMed Web of Science ®Google Scholar
• Behere RV, Arasappa R, Jagannathan A, et al. Effect of yoga therapy on facial emotion recognition deficits, symptoms and functioning in patients with schizophrenia. Acta Psychiatr Scand. 2011;123(2):147–153.
   PubMed Web of Science ®Google Scholar
• Vancampfort D, De Hert M, Knapen J, et al. State anxiety, psychological stress and positive well-being responses to yoga and aerobic exercise in people with schizophrenia: a pilot study. Disabil Rehabil. 2011;33(8):684–689.
   PubMed Web of Science ®Google Scholar
• Pajonk FG, Wobrock T, Gruber O, et al. Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry. 2010;67(2):133–143.
   PubMed Web of Science ®Google Scholar
• Kuo FC, Lee CH, Hsieh CH, Kuo P, Chen YC, Hung YJ. Lifestyle modification and behavior therapy effectively reduce body weight and increase serum level of brain-derived neurotrophic factor in obese non-diabetic patients with schizophrenia. Psychiatry Res. 2013;209(2):150–154.
   PubMed Web of Science ®Google Scholar
• Sylvia LG, Friedman ES, Kocsis JH, et al. Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. J Affect Disord. 2013;151(2):722–727.
   PubMed Web of Science ®Google Scholar
• Stanton R, Happell B. Exercise for mental illness: a systematic review of inpatient studies. Int J Ment Health Nurs. 2014;23(3):232–242.
   Web of Science ®Google Scholar
• Oertel-Knöchel V, Mehler P, Thiel C, et al. Effects of aerobic exercise on cognitive performance and individual psychopathology in depressive and schizophrenia patients. Eur Arch Psychiatry Clin Neurosci. Epub February 2, 2014.
   Google Scholar
• Neeper SA, Gómez-Pinilla F, Choi J, Cotman C. Exercise and brain neurotrophins. Nature. 1995;373(6510):109.
   PubMed Web of Science ®Google Scholar
• Gustafsson G, Lira CM, Johansson J, et al. The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder. Psychiatry Res. 2009;169(3):244–248.
   Web of Science ®Google Scholar
• Laske C, Banschbach S, Stransky E, et al. Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression. Int J Neuropsychopharmacol. 2010;13(5):595–602.
   PubMed Web of Science ®Google Scholar
• Yarrow JF, White LJ, McCoy SC, Borst SE. Training augments resistance exercise induced elevation of circulating brain derived neurotrophic factor (BDNF). Neurosci Lett. 2010;479(2):161–165.
   PubMed Web of Science ®Google Scholar
• Seifert T, Brassard P, Wissenberg M, et al. Endurance training enhances BDNF release from the human brain. Am J Physiol Regul Integr Comp Physiol. 2010;298(2):R372–R377.
   PubMed Web of Science ®Google Scholar
• Goekint M, De Pauw K, Roelands B, et al. Strength training does not influence serum brain-derived neurotrophic factor. Eur J Appl Physiol. 2010;110(2):285–293.
   PubMed Web of Science ®Google Scholar
• Schiffer T, Schulte S, Hollmann W, Bloch W, Strüder HK. Effects of strength and endurance training on brain-derived neurotrophic factor and insulin-like growth factor 1 in humans. Horm Metab Res. 2009;41(3):250–254.
   PubMed Web of Science ®Google Scholar
• Zoladz JA, Pilc A, Majerczak J, Grandys M, Zapart-Bukowska J, Duda K. Endurance training increases plasma brain-derived neurotrophic factor concentration in young healthy men. J Physiol Pharmacol. 2008;59 Suppl 7:119–132.
   Google Scholar
• Ferris LT, Williams JS, Shen CL. The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med Sci Sports Exerc. 2007;39(4):728–734.
   PubMed Web of Science ®Google Scholar
• Schmolesky MT, Webb DL, Hansen RA. The effects of aerobic exercise intensity and duration on levels of brain-derived neurotrophic factor in healthy men. J Sports Sci Med. 2013;12(3):502–511.
   PubMed Web of Science ®Google Scholar
• Wise LA, Adams-Campbell LL, Palmer JR, Rosenberg L. Leisure time physical activity in relation to depressive symptoms in the Black Women’s Health Study. Ann Behav Med. 2006;32(1):68–76.
   PubMed Web of Science ®Google Scholar
• Babyak M, Blumenthal JA, Herman S, et al. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000;62(5):633–638.
   PubMed Web of Science ®Google Scholar
• Hoffman BM, Babyak MA, Craighead WE, et al. Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study. Psychosom Med. 2011;73(2):127–133.
   PubMed Web of Science ®Google Scholar
• Krogh J, Rostrup E, Thomsen C, Elfving B, Videbech P, Nordentoft M. The effect of exercise on hippocampal volume and neurotrophines in patients with major depression – a randomized clinical trial. J Affect Disord. 2014;165:24–30.
   PubMed Web of Science ®Google Scholar
• Acheson A, Conover JC, Fandl JP, et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature. 1995;374(6521):450–453.
   PubMed Web of Science ®Google Scholar
• Choi SH, Li Y, Parada LF, Sisodia SS. Regulation of hippocampal progenitor cell survival, proliferation and dendritic development by BDNF. Mol Neurodegener. 2009;4:52.
   Web of Science ®Google Scholar
• Kazlauckas V, Pagnussat N, Mioranzza S, et al. Enriched environment effects on behavior, memory and BDNF in low and high exploratory mice. Physiol Behav. 2011;102(5):475–480.
   PubMed Web of Science ®Google Scholar
• Sun H, Zhang J, Zhang L, Liu H, Zhu H, Yang Y. Environmental enrichment influences BDNF and NR1 levels in the hippocampus and restores cognitive impairment in chronic cerebral hypoperfused rats. Curr Neurovasc Res. 2010;7(4):268–280.
   Web of Science ®Google Scholar
• Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 2002;25(6):295–301.
   PubMed Web of Science ®Google Scholar
• Fang ZH, Lee CH, Seo MK, et al. Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats. Neurosci Res. 2013;76(4):187–194.
   PubMed Web of Science ®Google Scholar
• Noble EE, Mavanji V, Little MR, Billington CJ, Kotz CM, Wang C. Exercise reduces diet-induced cognitive decline and increases hippocampal brain-derived neurotrophic factor in CA3 neurons. Neurobiol Learn Mem. 2014;114C:40–50.
   Web of Science ®Google Scholar
• de Almeida AA, Gomes da Silva S, Fernandes J, et al. Differential effects of exercise intensities in hippocampal BDNF, inflammatory cytokines and cell proliferation in rats during the postnatal brain development. Neurosci Lett. 2013;553:1–6.
   PubMed Web of Science ®Google Scholar
• Aguiar AS Jr, Stragier E, da Luz Scheffer D, et al. Effects of exercise on mitochondrial function, neuroplasticity and anxio-depressive behavior of mice. Neuroscience. 2014;271:56–63.
   Web of Science ®Google Scholar
• Goda A, Ohgi S, Kinpara K, Shigemori K, Fukuda K, Schneider EB. Changes in serum BDNF levels associated with moderate-intensity exercise in healthy young Japanese men. Springerplus. 2013;2:678.
   Google Scholar
• Suzuki G, Tokuno S, Nibuya M, et al. Decreased plasma brain-derived neurotrophic factor and vascular endothelial growth factor concentrations during military training. PLoS One. 2014;9(2):e89455.
   PubMed Web of Science ®Google Scholar
• Bos I, Jacobs L, Nawrot TS, et al. No exercise-induced increase in serum BDNF after cycling near a major traffic road. Neurosci Lett. 2011;500(2):129–132.
   Web of Science ®Google Scholar
• Tang D, Lee J, Muirhead L, et al. Molecular and neurodevelopmental benefits to children of closure of a coal burning power plant in China. PLoS One. 2014;9(3):e91966.
   Web of Science ®Google Scholar
• Babaei P, Azali Alamdari K, Soltani Tehrani B, Damirchi A. Effect of six weeks of endurance exercise and following detraining on serum brain derived neurotrophic factor and memory performance in middle aged males with metabolic syndrome. J Sports Med Phys Fitness. 2013;53(4):437–443.
   Web of Science ®Google Scholar
• John AP, Koloth R, Dragovic M, Lim SC. Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Aust. 2009;190(4):176–179.
   PubMed Web of Science ®Google Scholar
• Christensen O, Christensen E. Fat consumption and schizophrenia. Acta Psychiatr Scand. 1988;78(5):587–591.
   PubMed Web of Science ®Google Scholar
• Molteni R, Barnard RJ, Ying Z, Roberts CK, Gómez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience. 2002;112(4):803–814.
   PubMed Web of Science ®Google Scholar
• Woo J, Shin KO, Park SY, Jang KS, Kang S. Effects of exercise and diet change on cognition function and synaptic plasticity in high fat diet induced obese rats. Lipids Health Dis. 2013;12:144.
   Web of Science ®Google Scholar
• Kaczmarczyk MM, Machaj AS, Chiu GS, et al. Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice. Psychoneuroendocrinology. 2013;38(9):1553–1564.
   PubMed Web of Science ®Google Scholar
• Yamada-Goto N, Katsuura G, Ochi Y, et al. Impairment of fear-conditioning responses and changes of brain neurotrophic factors in diet-induced obese mice. J Neuroendocrinol. 2012;24(8):1120–1125.
   PubMed Web of Science ®Google Scholar
• Yamada N, Katsuura G, Ochi Y, et al. Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology. 2011;152(7):2634–2643.
   Web of Science ®Google Scholar
• Peleg-Raibstein D, Luca E, Wolfrum C. Maternal high-fat diet in mice programs emotional behavior in adulthood. Behav Brain Res. 2012;233(2):398–404.
   PubMed Web of Science ®Google Scholar
• Balogun KA, Cheema SK. The expression of neurotrophins is differentially regulated by omega-3 polyunsaturated fatty acids at weaning and postweaning in C57BL/6 mice cerebral cortex. Neurochem Int. 2014;66:33–42.
   Web of Science ®Google Scholar
• Gama CS, Canever L, Panizzutti B, et al. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia. Schizophr Res. 2012;141(2–3):162–167.
   Web of Science ®Google Scholar
• Spencer JP, Vauzour D, Rendeiro C. Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects. Arch Biochem Biophys. 2009;492(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Jang SW, Liu X, Yepes M, et al. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci U S A. 2010;107(6):2687–2692.
   PubMed Web of Science ®Google Scholar
• Liu X, Chan CB, Jang SW, et al. A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J Med Chem. 2010;53(23):8274–8286.
   PubMed Web of Science ®Google Scholar
• Choi DC, Maguschak KA, Ye K, Jang SW, Myers KM, Ressler KJ. Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proc Natl Acad Sci U S A. 2010;107(6):2675–2680.
   Web of Science ®Google Scholar
• Choi DC, Gourley SL, Ressler KJ. Prelimbic BDNF and TrkB signaling regulates consolidation of both appetitive and aversive emotional learning. Transl Psychiatry. 2012;2:e205.
   Web of Science ®Google Scholar
• Andero R, Heldt SA, Ye K, Liu X, Armario A, Ressler KJ. Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry. 2011;168(2):163–172.
   PubMed Web of Science ®Google Scholar
• Andero R, Ressler KJ. Fear extinction and BDNF: translating animal models of PTSD to the clinic. Genes Brain Behav. 2012;11(5):503–512.
   PubMed Web of Science ®Google Scholar
• Apawu AK, Maina FK, Taylor JR, Mathews TA. Probing the ability of presynaptic tyrosine kinase receptors to regulate striatal dopamine dynamics. ACS Chem Neurosci. 2013;4(5):895–904.
   Web of Science ®Google Scholar
• Ren Q, Zhang JC, Fujita Y, Ma M, Wu J, Hashimoto K. Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine. Pharmacol Biochem Behav. 2013;106:124–127.
   PubMed Web of Science ®Google Scholar
• Yang YJ, Li YK, Wang W, et al. Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia. Pharmacol Biochem Behav. 2014;122:30–36.
   PubMed Web of Science ®Google Scholar
• Xu SL, Bi CW, Choi RC, et al. Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: a signaling response mediated by estrogen receptor. Evid Based Complement Alternat Med. 2013;2013:127075.
   PubMed Web of Science ®Google Scholar
• Oh SB, Park HR, Jang YJ, Choi SY, Son TG, Lee J. Baicalein attenuates impaired hippocampal neurogenesis and the neurocognitive deficits induced by γ-ray radiation. Br J Pharmacol. 2013;168(2):421–431.
   PubMed Web of Science ®Google Scholar
• Park SJ, Kim DH, Kim JM, et al. Mismatch between changes in baicalein-induced memory-related biochemical parameters and behavioral consequences in mouse. Brain Res. 2010;1355:141–150.
   Web of Science ®Google Scholar
• Rendeiro C, Foley A, Lau VC, et al. A role for hippocampal PSA-NCAM and NMDA-NR2B receptor function in flavonoid-induced spatial memory improvements in young rats. Neuropharmacology. 2014;79:335–344.
   Web of Science ®Google Scholar
• Williams CM, El Mohsen MA, Vauzour D, et al. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med. 2008;45(3):295–305.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Shioda N, Han F, et al. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res. 2009;1295:218–229.
   PubMed Web of Science ®Google Scholar
• Li F, Gong QH, Wu Q, Lu YF, Shi JS. Icariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by d-galactose in rats. Pharmacol Biochem Behav. 2010;96(3):301–305.
   Web of Science ®Google Scholar
• Kreijkamp-Kaspers S, Kok L, Grobbee DE, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA. 2004;292(1):65–74.
   Web of Science ®Google Scholar
• Bagheri M, Joghataei MT, Mohseni S, Roghani M. Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer’s disease. Neurobiol Learn Mem. 2011;95(3):270–276.
   PubMed Web of Science ®Google Scholar
• Xiong Z, Jiang B, Wu PF, et al. Antidepressant effects of a plant-derived flavonoid baicalein involving extracellular signal-regulated kinases cascade. Biol Pharm Bull. 2011;34(2):253–259.
   Web of Science ®Google Scholar
• Yi LT, Xu HL, Feng J, Zhan X, Zhou LP, Cui CC. Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin. Physiol Behav. 2011;102(1):1–6.
   Web of Science ®Google Scholar
• Li J, Zhou Y, Liu BB, et al. Nobiletin ameliorates the deficits in hippocampal BDNF, TrkB, and synapsin I Induced by chronic unpredictable mild stress. Evid Based Complement Alternat Med. 2013; 2013:359682.
   PubMed Web of Science ®Google Scholar
• Lv QQ, Wu WJ, Guo XL, et al. Antidepressant activity of astilbin: involvement of monoaminergic neurotransmitters and BDNF signal pathway. Biol Pharm Bull. 2014;37(6):987–995.
   Web of Science ®Google Scholar
• Wu X, Wu J, Xia S, Li B, Dong J. Icaritin opposes the development of social aversion after defeat stress via increases of GR mRNA and BDNF mRNA in mice. Behav Brain Res. 2013;256:602–608.
   PubMed Web of Science ®Google Scholar
• Ma X, Wang R, Zhao X, et al. Antidepressant-like effect of flaxseed secoisolariciresinol diglycoside in ovariectomized mice subjected to unpredictable chronic stress. Metab Brain Dis. 2013;28(1):77–84.
   PubMed Web of Science ®Google Scholar
• Al-Rahbi B, Zakaria R, Othman Z, Hassan A, Ahmad AH. Enhancement of BDNF concentration and restoration of the hypothalamic-pituitary-adrenal axis accompany reduced depressive-like behaviour in stressed ovariectomised rats treated with either Tualang honey or estrogen. ScientificWorldJournal. 2014;2014:310821.
   Google Scholar
• Corona G, Vauzour D, Hercelin J, Williams CM, Spencer JP. Phenolic acid intake, delivered via moderate champagne wine consumption, improves spatial working memory via the modulation of hippocampal and cortical protein expression/activation. Antioxid Redox Signal. 2013;19(14):1676–1689.
   Web of Science ®Google Scholar
• Gomez-Pinilla F, Nguyen TT. Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders. Nutr Neurosci. 2012;15(3):127–133.
   PubMed Web of Science ®Google Scholar
• De Nicoló S, Tarani L, Ceccanti M, et al. Effects of olive polyphenols administration on nerve growth factor and brain-derived neurotrophic factor in the mouse brain. Nutrition. 2013;29(4):681–687.
   PubMed Web of Science ®Google Scholar
• Lardner AL. Neurobiological effects of the green tea constituent theanine and its potential role in the treatment of psychiatric and neurodegenerative disorders. Nutr Neurosci. 2014;17(4):145–155.
   PubMed Web of Science ®Google Scholar
• de Beaufort I. ‘Please, sir, can I have some more?’ Food, lifestyle, diets: respect and moral responsibility. Best Pract Res Clin Gastroenterol. 2014;28(2):235–245.
   Web of Science ®Google Scholar